in schizophrenia physiological relevance. It would be a minute fraction of the total pool of this mRNA in a given cell, SIR -We read with considerable interest the recent as the vast majority would be in the raphe cell bodreport by Hernandez and Sokolov entitled 'Abnormal ies. Such an mRNA would be unlikely to be transexpression of serotonin transporter mRNA in the fronlated in the axon terminal. While this possibility tal and temporal cortex of schizophrenics.' In this seems more likely than our first, the detection of a paper, the authors found changes in serotonin transtranscript here is difficult to interpret, and certainly porter mRNA in some cortical regions, specifically a does not correspond with previous studies on transdecrease of this mRNA in Brodmann areas 21 and 22, porter binding sites in cortex. and an increase in Brodmann area 9. While studies on (3) We feel that the most likely explanation is that the the neurochemical anatomy of schizophrenia are of authors have amplified a transcript other than seroconsiderable importance, we are troubled by the methtonin transporter mRNA. Given the high homology odology and subsequent interpretation of these data.
between known transporters, it seems possible that The authors performed this study in tissue punches, the authors have found an mRNA encoding another and identified serotonin transporter mRNA by PCR, folneurotransmitter transporter, but one that is lowed by electrophoresis of the resulting products and expressed locally in the cortex. Given that the image analysis of the gels. Apparently, the resulting authors did not sequence any of their amplified pro-PCR products were not sequenced to confirm the identducts, to conclude that the product is authentic seroity of the amplified molecule.
tonin transporter mRNA is unwarranted, and While the authors claim to be measuring the mRNA unlikely given what is known of the cell biology of encoding the serotonin transporter, this is highly susthese molecules. pect. In general, receptors and transporters are synthesized in or near the soma of a given cell, and the We agree that informed postmortem studies are of resulting protein is then transported to distal cell progreat importance in understanding schizophrenia. cesses (predominantly axons, in the case of the serotonin There is no doubt that Hernandez and Sokolov have transporter) for incorporation into the cell membrane.
identified some transcript (or population of transcripts) The consequence of this cellular biology is that when that is abnormal in schizophrenic cortex, or at the least transporter protein or binding sites are visualized in regulatable by antipsychotics. We doubt, however, that tissue sections, they are detected on the distal cell prothis molecule is a serotonin transporter mRNA. cesses, but the corresponding mRNA is usually seen only over the cell body. In the case of the study of Her-JH Meador-Woodruff and SJ Watson nandez and Sokolov, while the transporter itself may be University of Michigan expected to be detected in the frontal and temporal Mental Health Research Institute cortical regions studied, its mRNA would not be 205 Zina Pitcher Place expected to be visualized in these regions, but only in Ann Arbor, MI 48109-0720, USA the cell bodies that synthesized the transporter. (The vast e-mail:JIMMWȰUMICH.EDU majority of these cells that encode this transporter have their soma located in the raphe nuclei in the brainstem.)
It is clear from the discussion by these authors that they believe that the molecule(s) that they have amplified Sokolov replies -We would like to thank Dr Watson by PCR are associated with the raphe-cortical serotonin and Dr Meador-Woodruff for their interesting comprojection, which is doubtful. There appear to us to be ments on our report 'Abnormal expression of serotonin three more likely explanations for their observation:
transporter mRNA in the frontal and temporal cortex of schizophrenics' published recently in Molecular Psychiatry. They raised several issues that are (1) The serotonin transporter mRNA that was amplified is authentic serotonin transporter mRNA, but important not only in regard to our observations in schizophrenic brains, but also to some more fundamenis not encoded by the serotonin-synthesizing cells associated with the primary raphe projection to tal questions on the regulation and function of the serotonin transporter gene (SERT). cortex. For example, it is possible that they have detected low levels of this transporter mRNA in
The first question is, whether the mRNA that we measured in the cortex was indeed the authentic serointrinsic cortical cells, perhaps glia. This is probably the least likely possibility, as this transporter tonin transporter mRNA or, as suggested by Dr Watson and Dr Meador-Woodruff, this was some novel tranmRNA has not been previously found in either glia or intrinsic cortical neurons.
script that is abnormal in schizophrenic cortex? The identity of the mRNA in our work was confirmed by (2) A second possibility is that the authors have, in fact, amplified authentic serotonin transporter mRNA sequencing of PCR products. Three hundred and eighteen base pairs of the SERT fragment were synthesis. Moreover, emerging evidence indicates that translation of dendritic mRNAs may be regulated by sequenced and the sequence was identical to the pubsignaling events at synapses 9 and that local protein lished sequence of the SERT mRNA. 1 That the SERT synthesis within dendrites may be involved in longmRNA is present in frontal cortex has been previously term plasticity. 10 It should be noted however, that demonstrated in rat using RT-PCR followed by Southcomponents of the translational machinery have not ern blotting and sequence analysis. 2 Our preliminary yet been reported in the axon terminals, therefore the titration experiments mixing known amounts of pursignificance of mRNAs in axons remains unclear. ified SERT fragment indicated that SERT mRNA in Nevertheless, given the growing body of evidence indihuman cortex is in low abundance with about 1-5 copcating the role of mRNA transport in synaptic function, ies per cell (unpublished data). This explains why it the possible physiological role of SERT mRNA transwas not detectable in the cortex by Northern blotting port cannot be excluded a priori and deserves further but detectable using a more sensitive RT-PCR.
2 Thus, investigation. If indeed all or most of the cortical SERT experiments in both human and in rat brains demonmRNA is transported from the raphe nuclei, then the strate that serotonin transporter mRNA is apparently differential changes in its abundance in the frontal and present in cortex. The existence of another neurotemporal cortex of schizophrenics would imply differtransmitter transporter with high homology to SERT ential changes in the function or density of different appears to be unlikely. Firstly, only a single SERT serotonergic neurons in the raphe, projecting to differlocus was identified by chromosomal in situ hybridizent cortical areas, or suggest differential changes in the ation, arguing against the presence of a second gene SERT mRNA transport. with modestly divergent sequence. 1 Secondly, human Of note, the volume of cortical regions to which the SERT cDNA has been independently cloned from three raphe cell bodies are projecting is significantly larger different sources-placenta, midbrain raphe nuclei and than the volume of the raphe nuclei. Therefore, despite platelets. 1, 3, 4 The sequences of these three cDNAs were the fact that the concentration of SERT mRNA in cortex identical, indicating that they are encoded by the same is significantly lower than in the midbrain raphe comsingle-copy gene which has been assigned to the plex, its total amount in the cortex is probably compahuman chromosome 17.
1 It should also be noted that rable with the raphe. This implies that if the 'transport we used high stringency conditions in our PCR reachypothesis' is true, then the distal SERT mRNA is a tions (annealing temperature 68°C), to minimize a significant, not a minute fraction of the total pool of chance of non-specific co-amplification. Given that this mRNA in a given cell. SERT mRNA is expressed at high levels even in some
We certainly agree that it is crucial to use methods peripheral tissues (such as placenta, lung and in postmortem studies that would allow us to unamlymphoblasts), 1, 5 it is not very surprising that two out biguously verify whether or not what we measure is of two studies, which used such a sensitive method as what we intend to measure. Quantitative RT-PCR has RT-PCR, revealed SERT mRNA also in the cortex.
provided us with an excellent opportunity to identify The second question concerns the site of transcripthe source of the signal by direct sequencing. tion of SERT mRNA found in the cortex. One possi-A dysfunction of the serotonin transporter gene has bility is that the transcription occurs in some intrinsic been implicated in many psychiatric disorders. In this cortical neurons or glial cells. To our knowledge there regard we believe that the questions brought out by Dr is no published evidence that would clearly exclude Watson and Dr Meador-Woodruff are very timely and the this possibility. If indeed SERT mRNA is expressed in discussion of this matter in Molecular Psychiatry is very some intrinsic cells, what is its function there? Is it useful. We hope that this discussion may attract the attentranslated? Is the expression of serotonin transporter tion of other scientists to the topic of serotonin transtransient? What relevance does it have to schizoporter regulation in both normal and pathological states. phrenia and neuroleptic effects? It would be of a great interest to address these questions directly.
BP Sokolov Another possibility is that cortical SERT mRNA is Department of Psychiatry, Box 1229 transported from cell bodies located in the raphe to terMount Sinai School of Medicine minal regions of 5-HT pathways to initiate local seroOne Gustave L Levy Place tonin transporter synthesis. Evidence that certain New York, NY 10029, USA mRNAs are targeted to the subsynaptic cytoplasm and that local protein synthesis occurs there, is growing fast (for review see Ref. 6) . This is an exciting and rapidly developing direction of neuroscience which parallels a
